Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin in Japanese Prader-Willi Syndrome
NCT04697381Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Prader-Willi syndrome (PWS), sponsored by Pfizer. Started Feb 2021; status: completed.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT04697381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697381.